Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 250

1.

Topical Therapy with Antisense Tumor Necrosis Factor Alpha Using Novel β-Glucan-Based Drug Delivery System Ameliorates Intestinal Inflammation.

Sakisaka H, Takedatsu H, Mitsuyama K, Mochizuki S, Sakurai K, Sakisaka S, Hirai F.

Int J Mol Sci. 2020 Jan 20;21(2). pii: E683. doi: 10.3390/ijms21020683.

2.

Hepatitis B Virus Reactivation after Receiving Cancer Chemotherapy under Administration of Leuprorelin Acetate.

Yamauchi R, Takeyama Y, Takata K, Fukunaga A, Sakurai K, Tanaka T, Fukuda H, Fukuda S, Kunimoto H, Umeda K, Morihara D, Yokoyama K, Irie M, Shakado S, Sakisaka S, Hirai F.

Intern Med. 2020 Jan 17. doi: 10.2169/internalmedicine.3805-19. [Epub ahead of print]

3.

Hepatobiliary and Pancreatic: An intraperitoneal gallstone due to gallbladder perforation.

Takata K, Matsumoto K, Hirai F.

J Gastroenterol Hepatol. 2019 Dec 9. doi: 10.1111/jgh.14918. [Epub ahead of print] Review. No abstract available.

PMID:
31816661
4.

Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial.

Naganuma M, Yokoyama Y, Motoya S, Watanabe K, Sawada K, Hirai F, Yamamoto T, Hanai H, Omori T, Kanai T, Hibi T; CAPTAIN study Group.

J Gastroenterol. 2019 Dec 6. doi: 10.1007/s00535-019-01651-0. [Epub ahead of print]

PMID:
31811562
5.

Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.

Takamori S, Tagawa T, Toyokawa G, Shimokawa M, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Hirai F, Honda H, Maehara Y.

Ann Thorac Surg. 2019 Oct 23. pii: S0003-4975(19)31595-4. doi: 10.1016/j.athoracsur.2019.09.035. [Epub ahead of print]

PMID:
31655044
6.

Efficacy of enteral nutrition in patients with Crohn's disease on maintenance anti-TNF-alpha antibody therapy: a meta-analysis.

Hirai F, Takeda T, Takada Y, Kishi M, Beppu T, Takatsu N, Miyaoka M, Hisabe T, Yao K, Ueki T.

J Gastroenterol. 2020 Feb;55(2):133-141. doi: 10.1007/s00535-019-01634-1. Epub 2019 Oct 22. Review.

PMID:
31641874
7.

Refractive and visual outcomes after Ferrara corneal ring segment implantation at a 60% depth in keratoconic eyes: case series.

Renesto ADC, Hirai FE, Campos M.

Arq Bras Oftalmol. 2019 Aug 29;82(6):488-494. doi: 10.5935/0004-2749.20190091. eCollection 2019.

8.

A 3-year follow-up study of a new corneal inlay: clinical results and outcomes.

Beer SMC, Werner L, Nakano EM, Santos RT, Hirai F, Nitschke EJ, Francesconi Benicio C, Campos MSQ.

Br J Ophthalmol. 2019 Aug 24. pii: bjophthalmol-2019-314314. doi: 10.1136/bjophthalmol-2019-314314. [Epub ahead of print]

PMID:
31446390
9.

Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam.

Naganuma M, Hirai F, Kobayashi K, Watanabe K, Takeuchi K, Aoyama N, Nozawa H, Motoya S, Ohmori T, Harada A, Nagai Y, Abe T, Yamada Y, Inagaki K, Shimizu N, Kanai T, Watanabe M; ESCORT study Group.

PLoS One. 2019 Aug 5;14(8):e0220413. doi: 10.1371/journal.pone.0220413. eCollection 2019.

10.

The Use of Topiramate for Weight Loss Causing Acute Glaucoma: A Case Report and Literature Review.

DE Oliveira BMR, Ferrari PV, Herrerias BT, Hirai FE, Gracitelli CPB.

Med Hypothesis Discov Innov Ophthalmol. 2019 Summer;8(2):116-120.

11.

Prognosis of Early-stage Part-solid and Pure-solid Lung Adenocarcinomas.

Kinoshita F, Toyokawa G, Matsubara T, Kozuma Y, Haratake N, Takamori S, Akamine T, Hirai F, Takenaka T, Tagawa T, Maehara Y.

Anticancer Res. 2019 May;39(5):2665-2670. doi: 10.21873/anticanres.13391.

PMID:
31092466
12.

Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2).

Hisamatsu T, Kato S, Kunisaki R, Matsuura M, Nagahori M, Motoya S, Esaki M, Fukata N, Inoue S, Sugaya T, Sakuraba H, Hirai F, Watanabe K, Kanai T, Naganuma M, Nakase H, Suzuki Y, Watanabe M, Hibi T, Nojima M, Matsumoto T; DIAMOND2 Study Group.

J Gastroenterol. 2019 Oct;54(10):860-870. doi: 10.1007/s00535-019-01582-w. Epub 2019 Apr 30.

PMID:
31041545
13.

A novel prognostic marker in patients with non-small cell lung cancer: musculo-immuno-nutritional score calculated by controlling nutritional status and creatine kinase.

Takamori S, Toyokawa G, Shimokawa M, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Hirai F, Tagawa T, Oda Y, Maehara Y.

J Thorac Dis. 2019 Mar;11(3):927-935. doi: 10.21037/jtd.2019.01.76.

14.

Measurement of prostaglandin metabolites is useful in diagnosis of small bowel ulcerations.

Matsuno Y, Umeno J, Esaki M, Hirakawa Y, Fuyuno Y, Okamoto Y, Hirano A, Yasukawa S, Hirai F, Matsui T, Hosomi S, Watanabe K, Hosoe N, Ogata H, Hisamatsu T, Yanai S, Kochi S, Kurahara K, Yao T, Torisu T, Kitazono T, Matsumoto T.

World J Gastroenterol. 2019 Apr 14;25(14):1753-1763. doi: 10.3748/wjg.v25.i14.1753.

15.

Development of a C1q-immobilized (Cim) assay to measure total antibodies to infliximab and its clinical relevance in patients with inflammatory bowel disease.

Yoshimura N, Yokoyama Y, Sako M, Aoyama N, Hirai F, Sawada K, Kashiwagi N, Suzuki Y.

Cytokine. 2019 Aug;120:54-61. doi: 10.1016/j.cyto.2019.02.014. Epub 2019 Apr 16.

PMID:
31003189
16.

Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients.

Takamori S, Takada K, Azuma K, Jogo T, Shimokawa M, Toyokawa G, Hirai F, Tagawa T, Kawahara A, Akiba J, Okamoto I, Nakanishi Y, Oda Y, Hoshino T, Maehara Y.

Ann Surg Oncol. 2019 Jun;26(6):1916-1924. doi: 10.1245/s10434-019-07231-z. Epub 2019 Feb 27.

PMID:
30815801
17.

Effectiveness of monthly and fortnightly anti-VEGF treatments for age-related macular degeneration.

Nunes RP, Hirai FE, Barroso LF, Badaró E, Novais E, Rodrigues EB, Maia M, Magalhães O Jr, Farah ME.

Arq Bras Oftalmol. 2019 May-Jun;82(3):225-232. doi: 10.5935/0004-2749.20190043. Epub 2019 Feb 25.

18.

The Significance of CD44 Variant 9 in Resected Lung Adenocarcinoma: Correlation with Pathological Early-Stage and EGFR Mutation.

Akamine T, Tagawa T, Ijichi K, Toyokawa G, Takamori S, Hirai F, Okamoto T, Oda Y, Maehara Y.

Ann Surg Oncol. 2019 May;26(5):1544-1551. doi: 10.1245/s10434-018-07137-2. Epub 2019 Feb 24.

PMID:
30798450
19.

A case of recurrent keratitis caused by Paecilomyces lilacinus and treated by voriconazole.

Gracitelli CPB, Ferrar PV, Pereira CAP, Hirai FE, de Freitas D.

Arq Bras Oftalmol. 2019 Mar-Apr;82(2):152-154. doi: 10.5935/0004-2749.20190031.

20.

Phase I dose-escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors.

Esaki T, Hirai F, Makiyama A, Seto T, Bando H, Naito Y, Yoh K, Ishihara K, Kakizume T, Natsume K, Myers A, Doi T.

Cancer Sci. 2019 Apr;110(4):1340-1351. doi: 10.1111/cas.13956. Epub 2019 Feb 20.

21.

Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?

Yamaguchi M, Shimamatsu S, Edagawa M, Hirai F, Toyozawa R, Nosaki K, Seto T, Takenoyama M, Ichinose Y.

Surg Today. 2019 Mar;49(3):197-205. doi: 10.1007/s00595-018-1751-7. Epub 2019 Jan 4.

PMID:
30610361
22.

Differences in PD-L1 expression on tumor and immune cells between lung metastases and corresponding primary tumors.

Takamori S, Takada K, Tagawa T, Toyokawa G, Hirai F, Yamashita N, Okamoto T, Oki E, Yoshizumi T, Oda Y, Maehara Y.

Surg Oncol. 2018 Dec;27(4):637-641. doi: 10.1016/j.suronc.2018.08.001. Epub 2018 Aug 11.

PMID:
30449485
23.

Radiological Features of Programmed Cell Death-Ligand 2-positive Lung Adenocarcinoma: A Single-institution Retrospective Study.

Takada K, Toyokawa G, Azuma K, Takamori S, Jogo T, Hirai F, Tagawa T, Kawahara A, Akiba J, Okamoto I, Nakanishi Y, Oda Y, Hoshino T, Maehara Y.

In Vivo. 2018 Nov-Dec;32(6):1541-1550. doi: 10.21873/invivo.11412.

24.

Prognostic Impact of PD-L2 Expression and Association with PD-L1 in Patients with Small-cell Lung Cancer.

Takamori S, Takada K, Azuma K, Jogo Y, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Toyokawa G, Hirai F, Tagawa T, Okamoto I, Nakanishi Y, Kawahara A, Akiba J, Oda Y, Maehara Y.

Anticancer Res. 2018 Oct;38(10):5903-5907. doi: 10.21873/anticanres.12934.

PMID:
30275217
25.

PD-L2 Expression as a Potential Predictive Biomarker for the Response to Anti-PD-1 Drugs in Patients with Non-small Cell Lung Cancer.

Takamori S, Takada K, Toyokawa G, Azuma K, Shimokawa M, Jogo T, Yamada Y, Hirai F, Tagawa T, Kawahara A, Akiba J, Okamoto I, Nakanishi Y, Oda Y, Hoshino T, Maehara Y.

Anticancer Res. 2018 Oct;38(10):5897-5901. doi: 10.21873/anticanres.12933.

PMID:
30275216
26.

Capsule endoscopy findings for the diagnosis of Crohn's disease: a nationwide case-control study.

Esaki M, Matsumoto T, Ohmiya N, Washio E, Morishita T, Sakamoto K, Abe H, Yamamoto S, Kinjo T, Togashi K, Watanabe K, Hirai F, Nakamura M, Nouda S, Ashizuka S, Omori T, Kochi S, Yanai S, Fuyuno Y, Hirano A, Umeno J, Kitazono T, Kinjo F, Watanabe M, Matsui T, Suzuki Y.

J Gastroenterol. 2019 Mar;54(3):249-260. doi: 10.1007/s00535-018-1507-6. Epub 2018 Sep 15.

27.

Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial.

Hisamatsu T, Kunisaki R, Nakamura S, Tsujikawa T, Hirai F, Nakase H, Watanabe K, Yokoyama K, Nagahori M, Kanai T, Naganuma M, Michimae H, Andoh A, Yamada A, Yokoyama T, Kamata N, Tanaka S, Suzuki Y, Hibi T, Watanabe M; CERISIER Trial group.

Intest Res. 2018 Jul;16(3):494-498. doi: 10.5217/ir.2018.16.3.494. Epub 2018 Jul 27. No abstract available.

28.

Risk factors for severity of colonic diverticular hemorrhage.

Kinjo K, Matsui T, Hisabe T, Ishihara H, Kojima T, Chuman K, Yasukawa S, Beppu T, Koga A, Ishikawa S, Kishi M, Takatsu N, Hirai F, Yao K, Ueki T, Washio M.

Intest Res. 2018 Jul;16(3):458-466. doi: 10.5217/ir.2018.16.3.458. Epub 2018 Jul 27.

29.

Indoleamine 2,3-dioxygenase 1 and programmed cell death-ligand 1 co-expression correlates with aggressive features in lung adenocarcinoma.

Kozuma Y, Takada K, Toyokawa G, Kohashi K, Shimokawa M, Hirai F, Tagawa T, Okamoto T, Oda Y, Maehara Y.

Eur J Cancer. 2018 Sep;101:20-29. doi: 10.1016/j.ejca.2018.06.020. Epub 2018 Jul 13.

PMID:
30014971
30.

Phase II study of ceritinib in alectinib-pretreated patients with anaplastic lymphoma kinase-rearranged metastatic non-small-cell lung cancer in Japan: ASCEND-9.

Hida T, Seto T, Horinouchi H, Maemondo M, Takeda M, Hotta K, Hirai F, Kim YH, Matsumoto S, Ito M, Ayukawa K, Tokushige K, Yonemura M, Mitsudomi T, Nishio M.

Cancer Sci. 2018 Sep;109(9):2863-2872. doi: 10.1111/cas.13721. Epub 2018 Jul 25.

31.

Crohn's disease-specific mortality: a 30-year cohort study at a tertiary referral center in Japan.

Yasukawa S, Matsui T, Yano Y, Sato Y, Takada Y, Kishi M, Ono Y, Takatsu N, Nagahama T, Hisabe T, Hirai F, Yao K, Ueki T, Higashi D, Futami K, Sou S, Sakurai T, Yao T, Tanabe H, Iwashita A, Washio M.

J Gastroenterol. 2019 Jan;54(1):42-52. doi: 10.1007/s00535-018-1482-y. Epub 2018 Jun 9.

32.

Effect of a concomitant elemental diet with maintenance anti-tumor necrosis factor-α antibody therapy in patients with Crohn's disease: A multicenter, prospective cohort study.

Hirai F, Ishida T, Takeshima F, Yamamoto S, Yoshikawa I, Ashizuka S, Inatsu H, Mitsuyama K, Sou S, Iwakiri R, Nozaki R, Ohi H, Esaki M, Iida M, Matsui T; Additional Power of Elemental Diet on Maintenance Biologics Therapy in Crohn's Disease (ADORE) Study Group.

J Gastroenterol Hepatol. 2019 Jan;34(1):132-139. doi: 10.1111/jgh.14361. Epub 2018 Jul 16.

PMID:
29935082
33.

Long-term outcomes with Boston type 1 keratoprosthesis in ocular burns.

Magalhães FP, Hirai FE, Sousa LB, Oliveira LA.

Arq Bras Oftalmol. 2018 Jun;81(3):177-182. doi: 10.5935/0004-2749.20180038.

34.

Stevens-Johnson Syndrome Induced by Pembrolizumab in a Lung Cancer Patient.

Haratake N, Tagawa T, Hirai F, Toyokawa G, Miyazaki R, Maehara Y.

J Thorac Oncol. 2018 Nov;13(11):1798-1799. doi: 10.1016/j.jtho.2018.05.031. Epub 2018 Jun 6. No abstract available.

35.

Femtosecond laser-assisted deep anterior lamellar keratoplasty in phototherapeutic keratectomy versus the big-bubble technique in keratoconus.

de Macedo JP, de Oliveira LA, Hirai F, de Sousa LB.

Int J Ophthalmol. 2018 May 18;11(5):807-812. doi: 10.18240/ijo.2018.05.15. eCollection 2018.

36.

A case of different EGFR mutations in surgically resected synchronous triple lung cancer.

Haratake N, Takenoyama M, Edagawa M, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Yamaguchi M, Taguchi K, Seto T, Ichinose Y.

J Thorac Dis. 2018 Apr;10(4):E255-E259. doi: 10.21037/jtd.2018.03.105.

37.

Radiological Features of Brain Metastases from Non-small Cell Lung Cancer Harboring EGFR Mutation.

Takamori S, Toyokawa G, Shimokawa M, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Mukae N, Hirai F, Tagawa T, Oda Y, Iwaki T, Iihara K, Honda H, Maehara Y.

Anticancer Res. 2018 Jun;38(6):3731-3734. doi: 10.21873/anticanres.12653.

PMID:
29848735
38.

Prevalence of Enhancer of Zeste Homolog 2 in Patients with Resected Small Cell Lung Cancer.

Toyokawa G, Takada K, Tagawa T, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Takamori S, Akamine T, Hirai F, Yamada Y, Hamamoto R, Oda Y, Maehara Y.

Anticancer Res. 2018 Jun;38(6):3707-3711. doi: 10.21873/anticanres.12649.

PMID:
29848731
39.

Internal carotid artery aneurysm mimicking normal-tension glaucoma.

Pincelli Netto M, Ferrari PV, Herrerias BT, Hirai FE, Gracitelli CPB.

Arq Bras Oftalmol. 2018 Apr;81(2):148-152. doi: 10.5935/0004-2749.20180032.

40.

The significant influence of having children on the postoperative prognosis of patients with nonsmall cell lung cancer: A propensity score-matched analysis.

Takamori S, Tagawa T, Toyokawa G, Ueo H, Shimokawa M, Kinoshita F, Matsubara T, Kozuma Y, Haratake N, Akamine T, Katsura M, Takada K, Hirai F, Shoji F, Okamoto T, Oda Y, Maehara Y.

Cancer Med. 2018 May 29. doi: 10.1002/cam4.1539. [Epub ahead of print]

41.

Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study.

Koga A, Matsui T, Takatsu N, Takada Y, Kishi M, Yano Y, Beppu T, Ono Y, Ninomiya K, Hirai F, Nagahama T, Hisabe T, Takaki Y, Yao K, Imaeda H, Andoh A.

Intest Res. 2018 Apr;16(2):223-232. doi: 10.5217/ir.2018.16.2.223. Epub 2018 Apr 30.

42.

Significance of Spread Through Air Spaces in Resected Lung Adenocarcinomas With Lymph Node Metastasis.

Toyokawa G, Yamada Y, Tagawa T, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Takamori S, Akamine T, Hirai F, Oda Y, Maehara Y.

Clin Lung Cancer. 2018 Sep;19(5):395-400.e1. doi: 10.1016/j.cllc.2018.04.002. Epub 2018 Apr 18.

PMID:
29735272
43.

Successful Treatment of Growing Teratoma Syndrome of the Lung by Surgical Resection: A Case Report and Literature Review.

Tanaka K, Toyokawa G, Tagawa T, Ijichi K, Haratake N, Hirai F, Oda Y, Maehara Y.

Anticancer Res. 2018 May;38(5):3115-3118. Review.

PMID:
29715149
44.

Takotsubo Cardiomyopathy Developed After Two-stage Surgery for Double Primary Lung Cancer.

Kinoshita F, Toyokawa G, Tagawa T, Matsubara T, Kozuma Y, Haratake N, Takamori S, Akamine T, Hirai F, Maehara Y.

Anticancer Res. 2018 May;38(5):2957-2960.

PMID:
29715123
45.

Comparison of Small Bowel Lesions Using Capsule Endoscopy in Ulcerative Colitis and Crohn's Disease: A Single-Center Retrospective Analysis.

Ninomiya K, Hisabe T, Okado Y, Takada Y, Yamaoka R, Sato Y, Kishi M, Takatsu N, Matsui T, Ueki T, Yao K, Hirai F.

Digestion. 2018;98(2):119-126. doi: 10.1159/000487796. Epub 2018 Apr 26.

PMID:
29698945
46.

Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.

Akamine T, Takada K, Toyokawa G, Kinoshita F, Matsubara T, Kozuma Y, Haratake N, Takamori S, Hirai F, Tagawa T, Okamoto T, Yoneshima Y, Okamoto I, Shimokawa M, Oda Y, Nakanishi Y, Maehara Y.

Surg Oncol. 2018 Mar;27(1):88-94. doi: 10.1016/j.suronc.2018.01.002. Epub 2018 Jan 9.

PMID:
29549910
47.

The C-Reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study.

Takamori S, Toyokawa G, Shimokawa M, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Hirai F, Seto T, Tagawa T, Takenoyama M, Ichinose Y, Maehara Y.

Ann Surg Oncol. 2018 Jun;25(6):1555-1563. doi: 10.1245/s10434-018-6385-x. Epub 2018 Mar 2.

PMID:
29500763
48.

High Frequency of Spread Through Air Spaces in Resected Small Cell Lung Cancer.

Toyokawa G, Yamada Y, Tagawa T, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Takamori S, Akamine T, Hirai F, Oda Y, Maehara Y.

Anticancer Res. 2018 Mar;38(3):1821-1825.

PMID:
29491122
49.

Safety of Simultaneous Bilateral Pulmonary Resection for Metastatic Lung Tumors.

Matsubara T, Toyokawa G, Kinoshita F, Haratake N, Kozuma Y, Akamine T, Takamori S, Hirai F, Tagawa T, Okamoto T, Maehara Y.

Anticancer Res. 2018 Mar;38(3):1715-1719.

PMID:
29491107
50.

Evidence-based clinical practice guidelines for inflammatory bowel disease.

Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, Kato J, Kobayashi K, Kobayashi K, Koganei K, Kunisaki R, Motoya S, Nagahori M, Nakase H, Omata F, Saruta M, Watanabe T, Tanaka T, Kanai T, Noguchi Y, Takahashi KI, Watanabe K, Hibi T, Suzuki Y, Watanabe M, Sugano K, Shimosegawa T.

J Gastroenterol. 2018 Mar;53(3):305-353. doi: 10.1007/s00535-018-1439-1. Epub 2018 Feb 10.

Supplemental Content

Support Center